Reminder: Celestica to Hold 2025 Investor and Analyst Day Lunch Forum

GlobeNewswire
Oct 14, 2025

TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX and NYSE: CLS) would like to remind investors and analysts that it will host its 2025 Investor and Analyst Day Lunch Forum on October 28, 2025 in Midtown Manhattan, New York City.

Institutional investors and research analysts who wish to attend are invited to register here: Investor and Analyst Day Lunch Forum.

The 2025 Investor and Analyst Day Lunch Forum is an in-person event, scheduled to begin at 1:00 PM EST and will not be broadcast. Space for the event is limited, and attendance is subject to availability.

At the event, a panel of Celestica’s leadership team, including Rob Mionis, President and CEO, Mandeep Chawla, CFO, Jason Phillips, President, Connectivity & Cloud Solutions and other members of management will be available to answer questions from the institutional investor community.

The Lunch Forum will follow our 2025 Investor and Analyst Day and Q3 2025 financial results webcast during the morning, where management will provide an update on Celestica’s business operations, strategic priorities, growth opportunities and its financial outlook, and discuss our third quarter financial results. Participants are invited to join the morning webcast here: link.

Contact
Celestica Investor Relations
clsir@celestica.com

Celestica Investor Relations Events
events@ir.celestica.com


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10